the Image

Clinical Trial Details

If you are a patient or a caregiver and would like to learn more our cancer clinical trials call toll-free 1-855-702-8222 (adult trials) or 1-773-702-6808 (pediatric trials) or email cancerclinicaltrials@bsd.uchicago.edu .

Share this:
Brief Title Ibrutinib in Combination With Corticosteroids Versus Placebo in Combination With Corticosteroids in Subjects With New Onset Chronic Graft Versus Host Disease (cGVHD)
Official Title Ibrutinib in Combination With Corticosteroids Versus Placebo in Combination With Corticosteroids in Subjects With New Onset Chronic Graft Versus Host Disease (cGVHD) (iNTEGRATE)
Principal Investigator Artz, Andrew
Brief Summary To evaluate the safety and efficacy of ibrutinib in combination with prednisone in subjects with newly diagnosed moderate to severe cGVHD.
Gender All
Ages 12 Years
Enrollment 186
Accepts Healthy Volunteers No
Lead Sponsor Pharmacyclics LLC.Industry
Collaborator Janssen Research & Development, LLCIndustry
Study Design
Study Phase Phase 3
Study Type Interventional
Contact Name Mary Flowers
Contact Phone 1-855-702-8222 (adult trials) or 1-773-702-6808 (pediatric trials)
Condition Chronic Graft Versus Host Disease
Detail for Health Professional (on clinicaltrials.gov)
More clinical trials by this PI